Literature DB >> 20961909

Comment on: role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-β-lactamases.

Mariana Castanheira, Lalitagauri M Deshpande, Rodrigo E Mendes, Eduardo Rodriguez-Noriega, Ronald N Jones, Rayo Morfin-Otero.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20961909     DOI: 10.1093/jac/dkq393

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Expansion of clonal complex 258 KPC-2-producing Klebsiella pneumoniae in Latin American hospitals: report of the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Andrew J Costello; Lalitagauri M Deshpande; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-03       Impact factor: 5.191

2.  IMP-33, a New IMP variant detected in Pseudomonas aeruginosa from Sicily.

Authors:  Lalitagauri M Deshpande; Todd A Davies; Giovanna Blandino; Giuseppe Nicoletti; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 3.  B1-Metallo-β-Lactamases: Where Do We Stand?

Authors:  Maria F Mojica; Robert A Bonomo; Walter Fast
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

4.  His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.

Authors:  Hanna-Kirsti S Leiros; Susann Skagseth; Kine Susann Waade Edvardsen; Marit Sjo Lorentzen; Gro Elin Kjæreng Bjerga; Ingar Leiros; Ørjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

5.  Contemporary diversity of β-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent β-lactamase groups.

Authors:  Mariana Castanheira; Sarah E Farrell; Kevin M Krause; Ronald N Jones; Helio S Sader
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.